The results indicated that the relationship between patient immune treatment responses and their risk scores did not reach statistical significance, suggesting that patients in the high- and low-risk groups may not differ significantly in their responses to conventional ICB treatments (Fig. 11 f).
← all excerpts
Prognostic model identification of ribosome biogenesis-related genes in pancreatic cancer based on multiple machine learning analyses.
1
—
—